AMAM insider filings
Ambrx Biopharma, Inc. — 38 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-07. Screen AMAM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AMAM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Ambrx Biopharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-07 | 4 | Aromando Andrew — Chief Operating Officer | Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 371,428 (derivative) · Disposition to issuer (D): 55,570 (derivative) | EDGAR |
| 2024-03-07 | 4 | Loesberg Janet — Director | Disposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2024-03-07 | 4 | Hermans Kate — Director | Disposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) | EDGAR |
| 2024-03-07 | 4 | Nelson Sonja — Chief Financial Officer | Disposition to issuer (D): 22,936 · Disposition to issuer (D): 107,143 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 367,799 (derivative) · Disposition to issuer (D): 121,427 (derivative) · Disposition to issuer (D): 60,714 (derivative) · +1 more | EDGAR |
| 2024-03-07 | 4 | O'Connor Daniel J. — President and CEO, Director | Disposition to issuer (D): 48,202 · Disposition to issuer (D): 294,643 (derivative) · Disposition to issuer (D): 750,000 (derivative) · Disposition to issuer (D): 772,857 (derivative) · Disposition to issuer (D): 173,785 (derivative) | EDGAR |
| 2024-03-07 | 4 | Glover Stephen C. — Director | Disposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 5,714 (derivative) | EDGAR |
| 2024-03-07 | 4 | DALESANDRO MARGARET — Director | Disposition to issuer (D): 17,857 (derivative) · Disposition to issuer (D): 10,119 (derivative) | EDGAR |
| 2024-03-07 | 4 | MAIER PAUL V — Director | Disposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2023-12-11 | 4 | Aromando Andrew — Chief Operating Officer | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2023-12-11 | 4 | Nelson Sonja — Chief Financial Officer | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2023-12-11 | 4 | O'Connor Daniel J. — President and CEO, Director | Grant/award (A): 750,000 @ $0 | EDGAR |
| 2023-10-31 | 4 | Nelson Sonja — Chief Financial Officer | Sale (S): 12,778 @ $9.82 | EDGAR |
| 2023-10-31 | 4 | O'Connor Daniel J. — President and CEO, Director | Sale (S): 50,012 @ $9.82 | EDGAR |
| 2023-10-25 | 4 | Cormorant Asset Management, LP — 10% owner Chen Bihua — 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner | Purchase (P): 1,307,311 @ $6.99 | EDGAR |
| 2023-09-19 | 4 | Cormorant Asset Management, LP — 10% owner Chen Bihua — 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner | Purchase (P): 1,401,505 @ $9.05 · Purchase (P): 751,233 @ $9.24 | EDGAR |
| 2023-09-06 | 4 | DALESANDRO MARGARET — Director | Grant/award (A): 125,000 @ $0 · Grant/award (A): 70,833 @ $0 | EDGAR |
| 2023-07-07 | 4 | Aromando Andrew — Chief Operating Officer | Grant/award (A): 389,000 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Nelson Sonja — Chief Financial Officer | Grant/award (A): 389,000 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | O'Connor Daniel J. — President and CEO, Director | Grant/award (A): 1,216,500 (derivative) @ $0 | EDGAR |
| 2023-06-28 | 4 | Darwin Global Management, Ltd. — 10% owner Darwin Global Master Fund, Ltd. — 10% owner Trehan Abhishek — 10% owner | Purchase (P): 5,384,063 (derivative) @ $13.93 | EDGAR |
| 2023-06-09 | 4 | Chang Xiaowei — Director | Grant/award (A): 85,000 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Loesberg Janet — Director | Grant/award (A): 85,000 @ $0 | EDGAR |
| 2023-06-09 | 4 | Hermans Kate — Director | Grant/award (A): 85,000 @ $0 | EDGAR |
| 2023-06-09 | 4 | Glover Stephen C. — Director | Grant/award (A): 85,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | MAIER PAUL V — Director | Grant/award (A): 85,000 @ $0 | EDGAR |
| 2023-05-26 | 4 | Glover Stephen C. — Director | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Aromando Andrew — Chief Operating Officer | Grant/award (A): 2,600,000 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | Nelson Sonja — Chief Fin. & Operating Officer | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2023-04-28 | 4 | O'Connor Daniel J. — President and CEO, Director | Grant/award (A): 2,750,000 @ $0 | EDGAR |
| 2023-04-20 | 4 | Cormorant Asset Management, LP — 10% owner Chen Bihua — 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner | Purchase (P): 3,376,646 @ $11.27 · Purchase (P): 951,909 @ $11.15 · Purchase (P): 886,634 @ $11.60 | EDGAR |
| 2023-04-17 | 4 | Cormorant Asset Management, LP — 10% owner Chen Bihua — 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner | Purchase (P): 1,193,808 @ $9.16 · Purchase (P): 841,967 @ $9.96 · Purchase (P): 562,121 @ $10.67 | EDGAR |
| 2023-03-16 | 4 | Cormorant Asset Management, LP — 10% owner Chen Bihua — 10% owner Cormorant Global Healthcare Master Fund, LP — 10% owner Cormorant Private Healthcare Fund III LP — 10% owner | Purchase (P): 250,000 @ $9.95 · Purchase (P): 250,000 @ $10.60 · Purchase (P): 500,000 @ $10.15 | EDGAR |
| 2023-03-08 | 4 | Darwin Global Management, Ltd. — 10% owner | Purchase (P): 65,127 (derivative) @ $5.48 · Purchase (P): 39,957 (derivative) @ $6.02 · Purchase (P): 3,615,000 (derivative) @ $6.50 | EDGAR |
| 2023-01-31 | 4 | Rupalla Katrin — Director | Disposition to issuer (D): 200,000 (derivative) · Grant/award (A): 200,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative) | EDGAR |
| 2023-01-31 | 4 | Loesberg Janet — Director | Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative) | EDGAR |
| 2023-01-31 | 4 | Hermans Kate — Director | Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) | EDGAR |
| 2023-01-31 | 4 | Nelson Sonja — Chief Fin. & Operating Officer | Disposition to issuer (D): 2,574,596 (derivative) · Grant/award (A): 2,574,596 (derivative) · Disposition to issuer (D): 850,000 (derivative) · Grant/award (A): 850,000 (derivative) · Disposition to issuer (D): 425,000 (derivative) · Grant/award (A): 425,000 (derivative) | EDGAR |
| 2023-01-31 | 4 | MAIER PAUL V — Director | Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative) | EDGAR |
Recent 8-K events — Ambrx Biopharma, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-03-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-01-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-10-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-10-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AMAM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs